BRIEF published on 08/25/2026 at 10:00, 17 days ago Arkema Discloses Recent Share Buyback Activities Share Buyback XPAR EU Regulation Financial Strategy ARKEMA
PRESS RELEASE published on 08/25/2026 at 09:55, 17 days ago Informations privilégiées / Autres communiqués Arkema déclare les transactions sur actions propres du 17 au 21 août 2026, conformément à la réglementation. Détails disponibles sur le site web d'Arkema Actions Propres Transactions Réglementation Site Web ARKEMA
PRESS RELEASE published on 08/25/2026 at 09:55, 17 days ago Inside Information / Other news releases Arkema discloses trading in own shares from 17 to 21 August 2026, totaling 25,000 shares acquired at a weighted average price of 60.1182 EUR per share Share Buyback Trading Financial Disclosure Own Shares ARKEMA
BRIEF published on 08/18/2026 at 10:48, 23 days 23 hours ago Arkema publie ses transactions d'actions propres pour août 2026 Actions Propres Investissement Transactions ARKEMA Août 2026
BRIEF published on 08/18/2026 at 10:48, 23 days 23 hours ago Arkema Reports Share Buyback Transactions in August 2026 Share Buyback Financial Transactions EU Regulation ARKEMA August 2026
BRIEF published on 08/18/2026 at 10:48, 23 days 23 hours ago Arkema annonce des opérations de rachat d'actions en août 2026 Rachat D'actions Transactions Financières ARKEMA Règlement De L'UE Août 2026
BRIEF published on 08/18/2026 at 10:48, 23 days 23 hours ago Arkema publishes its treasury share transactions for August 2026 Transactions Investment ARKEMA Own Actions August 2026
PRESS RELEASE published on 08/18/2026 at 10:43, 23 days 23 hours ago Inside Information / Other news releases Arkema discloses trading in own shares from 10 to 14 August 2026 as per regulation. Total daily volume of 17,900 shares acquired with a weighted average price of 62,0572 Shares Trading Buyback Regulations ARKEMA
PRESS RELEASE published on 08/18/2026 at 10:43, 23 days 23 hours ago Informations privilégiées / Autres communiqués Arkema déclare les transactions sur actions propres effectuées du 10 août au 14 août 2026 selon la réglementation en vigueur Actions Propres Transactions Réglementation Achats D'actions ARKEMA
BRIEF published on 08/11/2026 at 11:04, 30 days 23 hours ago Arkema Reports Share Buyback Transactions in Early August 2026 Share Buyback Stock Market EU Regulation ARKEMA August 2026
Published on 09/11/2026 at 04:00, 6 hours 4 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 39 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 44 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 4 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 44 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 59 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 4 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 4 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 4 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 34 minutes ago Availability of the 2026 Interim Financial Report
